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Opuntia elatior, known as Nagaphani or Hathalo-thore belongs to the family Cactaceae. It is one of the Opuntia species 
used as medicine for various ailments due to its beneficial health-promoting properties. Fruits of Opuntia elatior have been 
advocated in anaemia, asthma, cough, inflammation, and gonorrhoea in Gujarat. The present study was planned to evaluate 
the hematinic effect of Opuntia elatior Mill. fruit on mercuric chloride (HgCl2) induced anaemia in rats. Opuntia elatior 
fruit Swarasa was administered to Charle’s foster albino rats for 30 consecutive days at the doses of 1.8 mL/kg and  
3.6 mL/kg. The effects of both drugs were assessed on ponderal changes, haematological, serum biochemical, and 
histopathology of various organs. The fruit Swarasa showed significant increase in the haemoglobin content, serum ferritin 
level and serum TIBC level. The test drug at both dose levels produced adverse changes of mild intensity in liver, kidney 
and heart and reverted the disturbance in the cytoarchitecture of the spleen, thymus and lymph node. Test drug Opuntia 
elatior fruit Swarasa reversed anaemia induced by HgCl2 in a dose-dependent manner. The results support the traditional use 
of fruits in the treatment of anaemia.  
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Introduction 
The WHO report shows that 35 to 40 % of women, 
43% of children below 5 years of age and 27 % of 
adolescents are anaemic in developing countries1. As 
per National Family Health Survey (NFHS-3), in 
India, the prevalence of anaemia was 70 % in children 
(6–59 months), 55 % in females (15–49 years), and 24 % 
in males (15–49 years) during 2005-20062. Iron is 
responsible for the transport of molecular oxygen in 
higher organisms3. Lack of iron shows a specific 
deficiency syndrome namely iron deficiency anaemia. 
This disease, though described many years ago in 
ancient classics by the name of Panduroga, has even 
today got its place among other diseases.  
Among some of the folklore claims, the presence 
of iron has been reported in the Swarasa of the fruit of 
Opuntia elatior Mill. belonging to the family 
Cactaceae4. This supports its ethnomedicinal claim in 
the management of anaemia and general debility. It is 
being used by the people of Gujarat as Nagaphani or 
Hathalo-thore. The Pharmacognostic evaluation of its 
stem has been reported earlier5. Its fruit is also a rich 
source of nutrients and vitamins6,7 and is eaten fresh, 
dried or preserved in jams, syrups or processed into 
candy-like products8,9. O. elatior is reported to 
possess anti-oxidant10, anti-asthmatic11, anti-ulcer12, 
anti-leukemic13, anti-inflammatory activity14 etc. In 
the previous study, haematinic evaluation O. elatior 
fruit juice was done at the higher dose level of (5, 10 
and 15 mL/kg) on mercuric chloride (HgCl2) anaemia 
in rats15. Till date, reports of the hematinic effect of 
this medicinal plant were not available at the dose 
prescribed in folklore practices. During extensive 
literature review, it was thought worthwhile to 
undertake detailed experimental study in modulating 
the extent and severity of anaemia in rats to 
substantiate its folklore claim at actual prescribed 
dose in practice. 
 
Materials and Methods 
 
Collection and preparation of test formulations  
The fresh fruits were daily collected around the 
place of Jamnagar, Gujarat. They were authenticated 
by the taxonomist of Pharmacognosy Department, 
Gujarat Ayurved University, Jamnagar and deposited 
in the museum (Specimen: phm/6138/1/1/2014) for 
future references. Freshly collected fruits were 
thoroughly washed with compressor nasal with an 
adequate amount of water and the bunch of thorns 
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over the fruits was neatly plucked using forceps. 
Following this, the outer skin of fruits was removed 
and the remaining part of fruits was macerated and the 
resultant juice obtained was passed through a sieve 
and filtered. The residue consisted of the sludge and 
seeds. The filtered juice was used for this 
experimental study. 
 
Animals  
Adult Charle’s foster albino rats of either sex, 
weighing between 200±20 g were obtained from the 
Animal house attached to Pharmacology laboratory. 
They were maintained under standard conditions of 
temperature (23±2 °C, relative humidity (50-60 %) 
and 12 h light and dark cycles. They were fed with 
diet Amrut brand rat pellet feed (Pranav Agro 
Industries) and drinking water ad libitum. The 
experimental protocol was approved by the 
Institutional Animal Ethical Committee 
(IAEC/16/2014/08) as per CPCSEA, India. 
 
Dose fixation 
In Ayurveda, the usual dose of Swarasa i.e. 
expressed juice is quoted to be 20 mL. The test dose 
of the drugs for the experimental study was calculated 
by extrapolating this human dose (20 mL per day) to 
animal dose based on the body surface area ratio by 
referring to the standard table of Paget and Barnes16. 
 
Haematinic activity 
In the present study, mercuric chloride (HgCl2) was 
used to induce anaemia in rats17. A solution of 
mercuric chloride was administered in 9 mg/kg dose 
through oral route for 30 days. In the treated group, 
suspension of test drugs was given along with 
mercuric chloride solution. Total 24 Charles Foster 
rats of either sex weighing between 180 to 250 g were 
taken and divided randomly into 4 groups, each 
containing 6 animals (3 male and 3 female). Group (I) 
received distilled water (5 mL/kg, p.o.), Group (II) 
received HgCl2 control group, Group (III) received 
juice of O. elatior Mill. therapeutically effective dose 
(TED) (1.8 mL/kg, p.o. equivalent to the dose of 
Swarasa i.e 20 mL per day, and Group (IV) received 
Juice of O. elatior Mill. TED*2 (3.6 mL/kg, p.o.) 
equivalent to double the dose i.e 40 mL per day.  
The test drugs and vehicle were administered for 
30 consecutive days. Mercuric chloride solution was 
administered orally to the group (III) and (IV) in a 
dose of 9 mg/kg after one of test drug administration 
daily. The same schedule was continued for 30 days 
with daily doses of test drugs and vehicle.  
Body weight was noted down before the 
commencement of the study and afterwards every 7th 
day along with general behaviour pattern by exposing 
each animal to open arena. Haematological and serum 
biochemical parameters were estimated on the day of 
sacrifice i.e. 31st day. On the 31st day, all animals 
were kept for overnight fasting. Next day blood was 
collected by supra-orbital puncture with the help of 
microcapillary tubes under mild ether anaesthesia for 
estimation of serum biochemical and haematological 
parameters and animals were sacrificed by an 
overdose of ether anaesthesia. The abdomen was 
opened through a midline incision.  
The haematological analysis was performed by 
using an automatic haematological analyzer (Swelab, 
Sweden). Total red blood cell (RBC), hemoglobin 
(Hb), hematocrit, mean corpuscular volume (MCV), 
mean corpuscular hemoglobin (MCH), mean 
corpuscular hemoglobin concentration (MCHC), 
white blood cell (WBC), neutrophils, lymphocyte 
percentage, eosinophils percentage, monocyte 
percentage, packed cell volume (PCV), and platelet 
count were measured from the blood samples.  
Serum biochemical parameters were carried out by 
using fully automated biochemical random access 
analyzer (BS-200, Lilac Medicare Pvt. Ltd., Mumbai). 
The studied parameters were blood glucose18, urea19, 
creatinine20, total cholesterol21, HDL-cholesterol22, 
triglyceride23, VLDL-cholesterol, LDL-cholesterol, 
total protein24, albumin25, alkaline phosphatase26, 
SGOT27, SGPT28, uric acid29, direct bilirubin, total 
bilirubin30, serum calcium31, serum iron32, serum 
ferritin and TIBC33. 
All the important internal organs were carefully 
dissected namely liver, heart, spleen and kidney. After 
noting signs of the gross lesion and ponderal changes 
of major organs, all were transferred to 10 % 
phosphate-buffered formalin solution for fixation and 
later on, subjected to dehydrating, wax embedding, 
sectioning and staining with haematoxylin and eosin 
for histological evaluation. The slides were viewed 
under trinocular research Carl-Zeiss’s microscope at 
various magnifications to note down the changes in 
the microscopic features of the tissues. 
 
Statistical analysis 
The data are expressed as mean±standard error of 
the mean for six rats per experimental group. Student 
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‘t’ test and one-way analysis of variance (ANOVA) 
was used to compare the mean values of 
quantitative variables among the groups followed 
by Dunnet’s multiple comparison test for unpaired 
data to determine the significant difference between 
groups at p <0.05. 
 
Results 
 
Effect on body weight 
Control group showed a significant increase in 
body weight during experimental period in 
comparison to initial values. HgCl2 treatment and 
drug-treated groups did not show any changes in body 
weight during the experimental period of 30 days 
(Table 1). TED and TED*2 group showed 
insignificant increase in the relative weight of thymus, 
TED*2 group showed insignificant increase in the 
relative weight of spleen, TED and TED*2 group 
showed non-significant effect in the relative weight of 
liver, TED and TED*2 group insignificant decrease 
was observed in kidney weight and TED group 
showed significant increase in heart weight as 
compared to HgCl2 group (Table 2). 
 
Effect on haematological parameters 
Test drug did not affect the WBC count. At the 
higher dose level, the test drug reverted the 
lymphocyte count and neutrophil count at non-
significant level in comparison to HgCl2 control 
group. Both dose level test drug produced non-
significant increase in monocyte count and 
significant increase in haemoglobin content in 
comparison to HgCl2 control group (Table 3).   
 
Biochemical parameters   
Test drug at both dose levels produced non-
significant decrease in blood sugar, blood urea, 
cholesterol and not affected the creatinine level in 
comparison to HgCl2 control group. Test drug at 
both dose levels did not affect the SGPT level. The 
TED dose level produced non-significant decrease 
while higher dose level did not affect the SGOT 
level in comparison to HgCl2 control group. Test 
drug at both dose levels did not affect the total 
protein level while TED dose level produced non-
significant decrease in alkaline phosphatase in 
comparison to HgCl2 control group. Test drug at 
both dose levels produced significant increase in 
serum ferritin and marked but non-significant 
increase in serum iron content in comparison to 
HgCl2 control group. Test drug at the TED*2 dose 
level produced non-significant decrease in 
triglyceride level in comparison to HgCl2 control 
group. Test drug at the TED dose level produced 
non-significant increase while higher level did not 
affect the HDL-cholesterol level in comparison 
to HgCl2 control group. Test drug at TED dose 
 level produced significant decrease in serum TIBC 
while TED*2 dose level produced the same 
magnitude of effect but failed to reach a significant 
level in comparison to HgCl2 control group 
(Table 4 & 5). 
Table 1 — Effect of different samples of on body weight 
Treatment Dose Initial body weight (g) Final body weight (g) Actual change (g) % change 
Control -- 181.67±9.80 205±5.00 23.33±9.19 12.84↑ 
HgCl2 9.0 mg/kg 201.67±8.72 201.67±11.08 0.0±7.30 0.49↑ 
TED 1.8 mL/kg 203.33±9.88 200.00±13.03 0.0±18.71 0.49↑ 
TED*2 3.6 mL/kg 186.67±7.14 196.00±9.27 8.00±9.69 4.28↓ 
Data presented as Mean±SEM, ↑= Increase, ↓= Decrease 
 
Table 2 — Effect of different samples on the relative weight of organs 
Organs  Groups 
Control(-) Change % HgCl2 (9.0 
mg/kg) 
Change % TED 
(1.8 mL/kg) 
Change % TED*2 
(3.6 mL/kg) 
Change % 
Spleen (mg/100 g) 189.73±14.20 - 186.80±14.79 1.54↓ 179.89±3.10 -- 202.28±14.60 8.28↑ 
Thymus (mg/100 g) 145.77±3.71 -- 150.42±6.28 3.19↑ 179.29±13.82 19.19↑ 159.59±4.79 6.09↑ 
Liver (g/100 g) 2.86±0.08 -- 2.81±0.12 1.677↓ 2.65±0.09 5.579↓ 2.80±0.10 0.42↓ 
Kidney (mg/100 g) 778.15±17.11 -- 856.96±27.45* 10.13↑ 838.56±37.39 2.15↓ 852.01±31.15 0.57↓ 
Heart (mg/100 g) 284.37±18.87 -- 272.76±9.01 4.08↓ 304.82±10.89* 11.75↑ 259.29±5.34 4.93↓ 
Data presented as Mean±SEM, ↑ = Increase, ↓ = Decrease 
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Effect on cytoarchitecture of different organs 
O. elatior fruit Swarasa at both dose levels to some 
extent reverted the changes induced in heart, kidney 
and liver. It was observed that there were minimal 
decrease in cellularity of white pulp in the spleen & 
thymus in drug treated groups as compared to changes 
induced by HgCl2 in disease control (Fig. 1-4). 
 
Discussion 
The mean body weight (g) of the albino rats in 
different treatment groups was recorded initially 
and after 30 days. Loss of body weight is a 
common clinical feature of anaemia. Test drug at 
both dose levels did not produce any significant 
effect on body weight parameters compared to 
HgCl2 group. HgCl2 group produced non-significant 
decrease in heart weight and significant increase in 
relative weight of kidney. The adverse changes 
manifested in histopathological findings in heart 
and kidney resembles the results found in a study 
by Chauhan et al15. The adverse changes were 
protected by test drug to a certain extent which was 
evident in heart, kidney and liver.  
Mercuric chloride altered the function of RBC by 
hemolysis characterized by decreased levels of RBC 
and haemoglobin in comparison to control group34. 
Haemoglobin estimation is considered as the marker 
for evaluating the correction of anemia15. In a 
previous study, the haemoglobin level showed a 
significant decrease in HgCl2 Control group35. The 
decrease may be the result of diminution in the 
number of circulating red cells, in the size of red cells, 
their concentration of haemoglobin or any 
combination of these36.  In iron deficiency anaemia, 
the reduction of red cells size MCV and MCH is the 
reason but reduction in cell number eventually  
Table 3 — Effect of Opuntia elatior fruit Swarasa on haematological parameters 
Parameters Groups  
Control 
(-) 
Change % HgCl2 (9.0 
mg/kg) 
Change % TED 
(1.8 mL/kg) 
Change % TED*2 
(3.6 mL/kg) 
Change % 
TWBC (103/mL) 8.70±0.635 -- 7.60±0.718 12.64↓ 6.70±0.363 11.84↓ 7.56±1.242 0.52↓ 
Lymphocyte (%) 78.67±5.41 -- 64.00±3.61a 18.64↓ 65.60±3.85 2.5↑ 69.60±5.44 8.75↑ 
Neutrophil (%) 17.50±5.37 -- 32.17±3.74a 83.81↑ 30.00±3.77 6.74↓ 26.20±5.20 18.55↓ 
Eosinophil (%) 2.16±0.167 -- 2.16±0.307 0 2.20±0.20 1.5↑ 2.40±0.245 10.75↑ 
Monocyte (%) 1.66±0.211 -- 1.66±0.333 0 2.20±0.200 31.97↑ 1.80±0.200 7.98↑ 
TRBC (106/mL) 8.78±0.208 -- 8.40±0.419 4.29 ↓ 8.51±0.203 1.34↑ 8.46±0.211 0.74↑ 
Hb (g/dL) 15.62± 0.29 -- 13.67±0.25a 12.48↓ 15.02±0.48* 9.87↑ 14.62±0.31* 6.95↑ 
PC (%) 49.07±1.29 -- 47.00±2.08 4.21↓ 46.22±0.80 1.66 ↓ 46.18±1.03 1.74↓ 
MCV (fl) 55.68±0.41 -- 56.03±0.97 0.63↑ 54.28±0.43 3.13↓ 54.54±0.18 2.66↓ 
MCH (pg/red cell) 17.77±0.27 -- 17.85±0.49 0.47↑ 17.20±0.26 3.64↓ 17.16±0.08 3.86↓ 
MCHC (g/dL) 31.90±0.42 -- 31.55±0.30 1.09↓ 31.64±0.24 0.28↑ 31.44±0.11 0.35↓ 
Data presented as Mean±SEM, ↑ = Increase, ↓ = Decrease 
ap < 0.01 when compared to control group *p <0.05 when compared to HgCl2 control group 
 
Table 4 — Effect of Opuntia elatior fruit Swarasa on biochemical parameters 
Parameters Groups  
Control 
(-) 
Change % HgCl2 
(9.0 mg/kg) 
Change % TED 
(1.8 mL/kg) 
Change % TED*2 
(3.6 mL/kg) 
Change % 
Blood Sugar (mg/dL) 65.33±2.18 -- 65.83±7.33 0.765↑ 54.60±4.83 17.06↓ 50.80±7.43 22.83↓ 
Serum 
Cholesterol (mg/dL) 
62.83±3.68 -- 62.83±4.65 0.0 59.00±1.38 6.10↓ 50.00±3.22 20.42↓ 
Triglycerides (mg/dL) 44.33±6.37 -- 45.17±4.12 1.88↑ 47.75±7.61 2.58↑ 39.00±2.66 13.65↓ 
HDL (mg/dL) 33.00±1.57 -- 29.50±1.19 10.60↓ 34.40±1.43 16.61↑ 28.20±1.40 4.40↓ 
Blood urea (mg/dL) 65.17±5.90 -- 77.17±4.53 18.41↑ 57.80±12.10 25.09↓ 66.40±7.82 77.17↓ 
Creatinin (mg/dL) 0.52±0.017 -- 0.48±0.017 10.60↓ 0.46±0.040 16.61↑ 0.50±0.032 4.40↓ 
SGPT (IU/L) 72.25±6.79 -- 83.67±6.93 15.80↓ 84.60±6.61 1.11↑ 80.80±4.46 3.42↓ 
SGOT (IU/L) 198.17±12.07 -- 228.17±21.06 15.14↑ 196.40±5.69 13.92↓ 219.40±22.83 3.84↓ 
Protein (g/dL) 7.15±0.178 -- 7.00±0.163 15.80↓ 6.76±0.103 1.11↑ 7.32±0.354 3.42↓ 
Albumin(g/dL) 157.25±31.36 -- 213.83±30.41 35.98↑ 127.40±14.62* 40.42↓ 219.66±45.94 -- 
Data presented as Mean±SEM, ↑ = Increase, ↓ = Decrease 
HDL: high-density lipoprotein; SGPT- Serum glutamic pyruvic transaminase; SGOT- Serum glutamic oxaloacetic transaminase 
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contribute to the anaemia. However, in the HgCl2 
Control group decrease observed in MCV and MCH 
was not significant. Hence, it may be suggested that 
the decrease in haemoglobin content is due to the 
decrease observed in the production of erythrocytes in 
the HgCl2 control group. The drug at both dose level 
significantly increases the haemoglobin content in 
comparison to HgCl2 Control group. The mean total 
and differential WBC count give the information 
regarding defence system of the body. Fruit juice of 
O. elatior improved the differential WBC count 
except for neutrophil in HgCl2 induced anaemia. The 
results were dose-dependent and protective against 
deleterious effect of HgCl2
 
in rats. Ferritin is a major 
iron-storage protein found principally in the liver, 
spleen, and bone marrow. For plasma (or serum) 
ferritin concentration to be a valid measure of iron 
status in rats, plasma ferritin concentration must 
respond to iron deficiency as well as iron repletion. 
Prolonged iron deficiency (3 to 10 weeks) tends to 
decrease mean plasma or serum ferritin concentration. 
In the present study, HgCl2 control group produced a 
significant decrease in serum ferritin, which may be 
due to significant loss/deficiency of iron content in 
the HgCl2 control group. Test drug at both dose level 
produced a significant increase in serum ferritin level 
which may be due to increased/restored iron content 
in comparison to HgCl2 control group.  
Total iron-binding capacity (TIBC) is a medical 
laboratory test that measures the blood's capacity to 
bind iron with transferrin. Taken together with serum 
iron and percent transferrin saturation clinicians 
usually perform this test when they are concerned 
about anaemia, iron deficiency or iron deficiency 
anaemia. However, because the liver produces 
transferrin, alterations in function must be considered 
when performing this test. It can also be an indirect 
test of liver function. In iron deficient anaemia the 
TIBC level increase may be due to liver producing 
Table 5 — Effect of Opuntia elatior fruit Swarasa on specific biochemical parameters 
Parameters Groups        
Control 
(-) 
Change % HgCl2 
(9.0 mg/kg) 
Change % TED 
(1.8 mL/kg) 
Change % TED*2 
(3.6 mL/kg) 
Change % 
S. Iron (µg/dL) 177.33±12.73 -- 123.00±9.32a 30.63↓ 139.40±5.20 13.33↓ 155.20±20.296 26.18↑ 
T.I.B.C (mg/dL) 275.17±7.04 -- 313.20±6.16 13.82↑ 293.00±2.65* 6.45↓ 291.20±14.73 7.02↓ 
Data presented as Mean±SEM, ↑ = Increase, ↓ = Decrease 
ap <0.01, bp  <0.001 when compared to control group 
*p <0.05 when compared to HgCl2 control group 
S.Iron- Serum iron, T.I.B.C- Total Iron Binding Capacity 
 
 
Fig. 1 — Photomicrographs of sections of the heart taken at 
X400 magnification. a) Normal cytoarchitecture (Control 
group), b) Fatty degenerative changes (HgCl2), c) Mild fatty 
degenerative changes (TED), and d) Mild fatty degenerative 
changes (TED*2) 
 
 
 
Fig. 2 — Photomicrographs of sections of kidney taken at X400 
magnification. a) Normal cytoarchitecture (Control group), b) 
Fatty degenerative changes, intense cell infiltration and edematous 
changes (HgCl2), c) Mild fatty and oedematous changes (TED), 
and d) Mild fatty and oedematous changes (TED*2) 
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more transferrin, presumably attempting to maximize 
use of the little iron that is available. In the present 
study, HgCl2 control group produced a non-significant 
increase in TIBC, which may be due to significant 
loss/deficiency of iron content in the HgCl2 control 
group. Test drug at lower dose produced significant 
while higher dose level produced non-significant 
decreases in serum TIBC level, which may be due to 
increased/restored iron content in comparison to 
HgCl2 control group. 
The kidney and liver get badly damaged by 
HgCl2
 
exposure37. Among human beings, inorganic 
Hg salt ingestion results in anuria and uremia from 
acute tubular necrosis38. Administration of HgCl2 
leads to fatty degenerative changes, intense cell 
infiltration and oedematous changes in kidney and 
fatty degenerative changes and oedema in liver 
and heart. The test drug at both dose level 
produced adverse changes of mild intensity hence 
revert the HgCl2 induced changes in liver, kidney 
and heart.  
The spleen is the storehouse of dead RBC and it 
is where the breakdown of haemoglobin occurs.  
Hemolytic anaemia leads to the accelerated 
breakdown of haemoglobin causing larger iron 
deposition in spleen39. This is likely to be the cause 
of fibrosis and lymphocytosis observed in the 
spleen in HgCl2 treated groups. HgCl2
 
treated also 
produced decreased in cellularity in thymus and 
lymph node. The disturbance in the cytoarchitecture 
of spleen, thymus and lymph node was significantly 
reversed by test drug administration. In this respect, 
fruit juice was comparatively better because, in 
addition to attenuating the fibrosis, it restored 
cellularity to moderate level thus inhibiting the 
toxicant-induced cell depletion in above organs 
(Fig. 1-4). 
 
Conclusion 
O. elatior fruit Swarasa at both dose levels 
significantly increase the haemoglobin content, 
serum ferritin level in comparison to HgCl2 Control 
group and protected the damage caused by HgCl2
 
in 
rats. Fruit juice was comparatively better because, 
in addition to attenuating the fibrosis, it restored 
cellularity to moderate level thereby inhibiting the 
toxicant-induced cell depletion in kidney, liver, 
heart and spleen. These results support the 
traditional use of fruits in the treatment of anaemia. 
Though human physiology differs from the lower 
animals like rats, it would be prudent to watch 
efficacy of test drugs in clinical settings especially 
when administered for a longer duration. 
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Fig. 3 — Photomicrographs of sections of liver taken at X400 
magnification. a) Normal cytoarchitecture (Control group), b) 
Fatty degenerative changes and oedema (HgCl2), c) Mild fatty 
changes (TED), and d) Mild fatty changes (TED*2) 
 
 
 
Fig. 4 — Photomicrographs of sections of spleen taken at X400 
magnification. a) Normal cytoarchitecture (Control group), b) 
Severe lymphocytosis, decreased in white pulp and fibrosis 
(HgCl2), c) mild decrease in cellularity and white pulp (TED), and 
d) Mild decrease in cellularity and white pulp (TED*2) 
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